Zobrazeno 1 - 10
of 16
pro vyhledávání: '"Markus Weigandt"'
Autor:
Christian Jede, Lassina Badolo, Christian Wagner, Christian Weber, Markus Weigandt, Mirko Koziolek, Holger Kubas, Werner Weitschies, Marc Lecomte
Publikováno v:
Molecular Pharmaceutics. 16:3938-3947
The characterization of intestinal dissolution of poorly soluble drugs represents a key task during the development of both new drug candidates and drug products. The bicarbonate buffer is considered as the most biorelevant buffer for simulating inte
Autor:
Christian Wagner, Christian Jede, Werner Weitschies, Christian Weber, Holger Kubas, Mirko Koziolek, Markus Weigandt
Publikováno v:
International Journal of Pharmaceutics. 565:458-471
The majority of NCEs are weakly basic drugs. Consequently, their solubility is highly pH-dependent, with higher solubility in the acidic stomach and poor solubility in the neutral intestinal environment. The gastric emptying of dissolved drug can lea
Publikováno v:
European Journal of Pharmaceutics and Biopharmaceutics. 101:126-136
The treatment of joint related diseases often involves direct intra-articular injections. For rational development of novel delivery systems with extended residence time in the joint, detailed understanding of transport and retention phenomena within
Autor:
Markus Weigandt, Holger Kubas, Mirko Koziolek, Christian Jede, Christian Wagner, Werner Weitschies, Christian Weber
Publikováno v:
International journal of pharmaceutics. 556
Precipitation testing, especially for weakly basic APIs, represents a key parameter in drug substance characterization during early development stages, where the amount of API available is limited. Therefore, it was the aim of this study to develop a
Autor:
Senta Uezguen, Mariola Monika Golas, Bjoern Sander, Achim Goepferich, Gwenaelle van Colen, Markus Weigandt, Tobias Miller
Publikováno v:
Miller, T, van Colen, G, Sander, B, Golas, M M, Uezguen, S, Weigandt, M & Goepferich, A 2013, ' Drug Loading of Polymeric Micelles ', Pharmaceutical Research, vol. 30, no. 2, pp. 584-595 . https://doi.org/10.1007/s11095-012-0903-5
PURPOSE: To gain mechanistic insights into drug loading and lyophilization of polymeric micelles.METHODS: PEGylated poly-4-(vinylpyridine) micelles were loaded with dexamethasone. Three different methods were applied and compared: O/W emulsion, direc
Publikováno v:
Biomacromolecules. 13:1707-1718
Polymeric micelles are ideal carriers for solubilization and targeting applications using hydrophobic drugs. Stability of colloidal aggregates upon injection into the bloodstream is mandatory to maintain the drugs' targeting potential and to influenc
Publikováno v:
International journal of pharmaceutics. 461(1-2)
Crystal suspensions of 3 poorly soluble peptides (MSC1, 2 and 3), intended for intra-articular administration were prepared and in vitro release was tested by a modified USP IV apparatus, combined with a dialysis system. Half-lives of release profile
Publikováno v:
International journal of pharmaceutics. 451(1-2)
Utilizing poorly soluble drug candidates in pharmacokinetic studies remains challenging in preclinical drug development. We investigated a nanosuspension-based delivery system to achieve constant drug plasma levels by applying the nanoparticles via s
Autor:
Markus Weigandt, Karsten Mäder, Uwe Haberkorn, Simon Geissler, Sandra Breyer, Walter Mier, Alexandra Hill
Publikováno v:
Journal of controlled release : official journal of the Controlled Release Society. 168(1)
In research and development sufficiently high and constant plasma levels of drug candidates are often requested, but simple solutions of hydrophobic drugs delivered from the commonly used micro-osmotic pumps cannot meet these demands. Nanosuspensions
Autor:
Markus Weigandt, Gwenaelle van Colen, Uwe Haberkorn, Senta Voss, Achim Goepferich, Tobias Miller, Simon Geissler, Walter Mier, Sandra Breyer
Publikováno v:
International journal of pharmaceutics. 445(1-2)
Based on the enhanced permeability and retention (EPR) effect, nanoparticles are believed to accumulate in tumors. In this conjunction, the stability of drug encapsulation is assumed to be sufficient. For clarification purposes, PEGylated poly-(d,l-l